pulse compensation is disclosed for electronic devices capable of producing a pulse output signal suitable for therapeutic purposes with pulse compensation being automatically provided upon sensing of a change in she conditions being monitored. The electronic device, which preferably includes a microcomputer, has externally accessible pulse width and intensity controls for determining the width and amplitude of pulses then being delivered. Upon each sensing of a change in a monitored condition capable of causing user discomfort or possible injury, the intensity of the pulses then being delivered is quickly reduced and then gradually increased toward the full intensity requested by the intensity control. pulse compensation is also provided when the pulse width is varied by the pulse width control to thereby automatically cause a corresponding change in the range of intensities of the pulses then delivered, based upon a nerve fiber strength-duration curve or the pulses, to thereby maintain the stimulation capability of the pulses substantially constant at a percentage of intensity as determined by the intensity control.

Patent
   RE35987
Priority
Feb 08 1995
Filed
Feb 08 1995
Issued
Dec 08 1998
Expiry
Dec 08 2015
Assg.orig
Entity
Small
135
29
all paid
22. A method for providing output pulse compensation in an electronic device providing output pulses having a variable intensity level for therapeutic purposes and having output means that includes a transistor with a drain having a drain voltage, said method comprising:
providing sensing means for sensing the drain voltage of said transistor of said output means indicative of a change in at least one predetermined condition being then monitored;
providing sample and hold means for receiving the sensed drain voltage of said transistor indicative of said change in said predetermined condition then being monitored; and
causing a rapid decrease in the intensity level of said output pulses upon sensing of said change in said predetermined condition and then, upon completion of said decrease of intensity level, gradually increasing the intensity level of said output pulses over a predetermined time period toward the intensity level of said output pulses existing immediately prior to said rapid decrease.
18. A method for providing output pulses for therapeutic purposes, said method comprising:
providing control pulses;
providing a voltage output;
providing an output means having transistor means for receiving said control pulses and said voltage output and, responsive thereto, providing output pulses having an intensity level and a pulse width subject to change due to the occurrence of predetermined condition variations;
sensing the occurrence of saturation of said transistor means indicative of a one of the predetermined condition variation variations capable of causing user discomfort while said output pulses are being provided; and
utilizing said sensed occurrence of said predetermined condition variation to cause intensity compensation of said output pulses by causing the intensity level of said output pulses to be quickly reduced to a predetermined intensity level and then upon completion of said reduction, causing the intensity level of said output pulses to be gradually increased toward the intensity level of said output pulses existing prior to sensing of the occurrence of said predetermined condition variation.
6. In an electronic device for providing output pulses having a variable intensity level for therapeutic purposes and having output means for producing said pulses that includes a transistor with a drain having a drain voltage, output pulse compensation means comprising first means including sensing means connected with said output means for sensing the drain voltage of said transistor indicative of a change in at least one predetermined condition being then monitored and sample and hold means connected with said sensing means whereby said sample and hold means receives the sensed drain voltage of said transistor, and second means connected with said sample and hold means for causing a rapid decrease in the intensity level of said output pulses upon sensing of said change in at least one predetermined condition being then monitored, said second means, upon completion of said rapid decrease in intensity level, then causing the intensity level of said output pulses to be thereafter gradually increased over a predetermined time period toward the intensity level of said output pulses existing immediately prior to said rapid decrease.
25. A method for providing pulse width compensation in an electronic device providing output pulses for therapeutic purposes, wherein each of the pulses has an intensity and a pulse width that produces a charge that has a resulting capability to stimulate nerve fiber, said method comprising:
establishing a percentage of maximum intensity of the output pulses within a range of intensities, wherein the range of intensities has a maximum intensity that is based on the pulse width in a strength-duration curve relationship and wherein the intensity equals the established variable percentage of the maximum intensity;
sensing determining a change in the pulse width of the output pulses being then delivered;
determining a new range of intensities with a new maximum based upon a said strength-duration curve relationship for said output pulses that corresponds to said change in pulse width; and
providing output pulses having changed pulse width with said output pulses having said established percentage of maximum intensity within said then determined range of intensities of said output pulses maintained to thereby also maintain such that the resulting capability to stimulate nerve fiber of the charge delivered per pulse of said output pulses is maintained substantially constant.
10. An electronic device for providing output pulses for therapeutic purposes, said device comprising:
electronic controller means for providing control pulses;
voltage supply means for providing a voltage output;
pulse output means for receiving said control pulses and said voltage output and, responsive thereto, providing output pulses having an intensity level for therapeutic purposes, said pulse output means including transistor means having a drain with a drain voltage; and
said electronic controller means including sample and hold means connected with said transistor means for sensing the drain voltage of said transistor means and capacitor means for storing a voltage indicative of said drain voltage, said electronic controller means receiving said voltage stored at said capacitor means and, responsive to a an amount of stored voltage indicative of the occurrence of a predetermined condition variation, causing intensity compensation of said output pulses by rapidly decreasing the intensity level of said output pulses and thereafter gradually increasing the intensity level of said output pulses over a predetermined period of time toward the intensity level of said output pulses existing immediately prior to said rapid decrease in intensity level.
20. A method for providing output pulses for therapeutic purposes, said method comprising:
providing control pulses;
providing a voltage output;
receiving said control pulses and said voltage output and, responsive thereto, providing output pulses having an intensity and pulse width subject to change due to the occurrence of predetermined condition variations that produces a charge that has a resulting capability to stimulate nerve fiber, said intensity being variable within a range of intensities, wherein the range of intensities has a maximum intensity that is based on the pulse width in a strength-duration curve relationship and wherein said intensity equals a variable percentage of the maximum intensity;
providing pulse width control means for varying the pulse width of said output pulses;
providing intensity percentage control means for varying the percentage of the maximum intensity of for said output pulses; and
sensing of a predetermined condition variation established by varying that is indicative of a variation in the pulse width of the output pulses by said pulse width control means, and responsive thereto, causing the a corresponding and predetermined change in the range of intensities of said output pulses based upon a said strength-duration curve applicable to said output pulses, said and causing a change in the range of intensities intensity of said output pulses being in a manner such that the intensity of the output pulses are substantially maintained at said percentage of the maximum intensity as established varied by said intensity percentage control means is substantially maintained.
1. An electronic device for providing output pulses to a user for therapeutic purposes, said device comprising:
electronic controller means for providing control pulses;
voltage supply means for providing a voltage output;
pulse output means including transistor means for receiving said control pulses and said voltage output and, responsive thereto, providing output pulses for therapeutic purposes having an intensity level and a pulse width subject to change due to the occurrence of predetermined condition variations; and
said electronic controller means including sensing means connected with said transistor means for sensing saturation of said transistor means indicative of the occurrence of a one of the predetermined condition variation variations capable of causing user discomfort while said output pulses are being provided, and, responsive thereto, said electronic controller means causing intensity compensation of said output pulses by causing the intensity level of said output pulses to be quickly reduced to a predetermined intensity level and then, upon completion of said reduction, causing the intensity level of said output pulses to be gradually increased toward the intensity level of said output pulse existing immediately prior to sensing of the occurrence of said predetermined condition variation.
4. An electronic device for providing output pulses for therapeutic purposes, said device comprising:
electronic controller means for providing control pulses;
voltage supply means for providing a voltage output;
pulse output means for receiving said control pulses and said voltage output and, responsive thereto, providing output pulses for therapeutic purposes having an intensity and a pulse width subject to change due to the occurrence of predetermined condition variations, said intensity being variable within a range of intensities, wherein the range of intensities has a maximum intensity that is based on the pulse width in a strength-duration curve relationship and wherein said intensity equals a variable percentage of the maximum intensity;
pulse width control means for varying the pulse width of said output pulses;
intensity percentage control means for varying the percentage of the maximum intensity of for said output pulses; and
said electronic controller means including sensing means for sensing a predetermined condition variation establishing that is indicative of a change in the pulse width of the output pulses by said pulse width control means, and, responsive thereto, causing a corresponding and predetermined change in the range of intensities of said output pulses based upon a said strength-duration curve applicable to said output pulses, said and causing a change in the range of intensities intensity of said output pulses being pulse in a manner such that the intensity of the output pulse is substantially maintained at the percentage of the maximum intensity as established varied by said intensity percentage control means is substantially maintained.
12. In an electronic device for providing a pulse output signal pulses for therapeutic purposes with, each of said output pulses having a pulse width and intensity, said electronic device having pulse width control means for varying the pulse width of said pulse output signal pulses and intensity percentage control means for varying the percentage of intensity of said output pulses, pulses to produce a charge for each output pulse that has a resulting capacity to stimulate nerve fiber pulse width compensation means comprising:
intensity percentage control means for variably setting a percentage of a maximum intensity for the intensity of the output pulses, wherein said maximum intensity is defined by a strength-duration curve relationship between pulse width and intensity for nerve fiber stimulation capability such that there is a range of intensities limited by the maximum intensity for a pulse width;
sensing means for sensing a change in the pulse width of said pulse output signal by said pulse width control means and providing an output indicative thereof; and
electronic means for causing a change in the intensity and in the range of intensities of said pulse output signal pulses responsive to said output from said sensing means, with said change in the intensity and in the range of intensities of said pulse output signal pulses being in a manner such that the intensity of said output pulses is substantially maintained at the percentage of maximum intensity in the range of intensities as established varied by said intensity percentage control means is substantially maintained, and with said change in the range of intensities of said pulse output signal being based upon a the strength-duration curve applicable to said delivered output pulses of said pulse output signal to thereby maintain such that the resulting capability to stimulate nerve fiber of the charge delivered per for each pulse of said pulse output signal is maintained substantially constant.
15. An electronic device for providing output pulses for therapeutic purposes, each of which output pulses has a pulse width and intensity to produce a charge for each output pulse that has a resulting capability to stimulate nerve fiber, said device comprising:
pulse width control means for varying the pulse width of said output pulses, wherein the intensity of the output pulses is variable within a range of intensities, and wherein the range of intensities has a maximum intensity that is based on the pulse width in a strength-duration curve relationship;
amplitude intensity percentage control means for varying the percentage of the maximum intensity for said output pulses;
controller means connected with said pulse with width control means and said amplitude intensity percentage control means, said controller means providing control pulses, each pulse of which control pulses has a width and an amplitude intensity determined by said pulse width control means and said amplitude intensity percentage control means;
high voltage supply means for providing a high voltage output;
pulse output means for receiving said control pulses and said high voltage output and, responsive thereto, providing output pulses for therapeutic purposes; and
said controller means also providing pulse compensation for causing a change in the range of intensities of said output pulses responsive to a variation in said pulse width of said output pulses effected by said pulse width control means, with said change in the range of intensities of said output pulses being based upon a said strength-duration curve applicable to said delivered output pulses to thereby maintain relationship such that the resulting capability to stimulate nerve fiber of the charge delivered per pulse for each of said output pulses is maintained substantially constant and with the causing a change in the range of intensities of said output pulses responsive to variation in pulse width being in a manner such that the intensity of each output pulse is substantially maintained at the percentage of the maximum intensity established as varied by said amplitude intensity percentage control means is substantially maintained so that the intensity level delivered within said range of intensities is such that the delivered charge that stimulates nerve fiber remains unchanged by a change in pulse width by said pulse width control means.
2. The device of claim 1 wherein said electronic controller means allows the intensity level of said output pulses to be gradually increased over a predetermined period of time toward said prior existing level unless said electronic controller means senses the occurrence of a one of the predetermined condition variation variations capable of causing user discomfort during said predetermined time period of gradual increase of the intensity level of said output pulses.
3. The device of claim 1 wherein said electronic controller means includes micro-computer means for causing generation of said control pulses and for effecting said intensity compensation of said output pulses.
5. The device of claim 4 wherein each of said output pulses delivers a charge that has a resulting capability to stimulate nerve fiber, and said electronic controller means causes said corresponding and predetermined change in the range of intensities of said output pulses to be such that the resulting capability to stimulate nerve fiber of the charge delivered per pulse of said output pulses is maintained substantially constant.
7. The device of claim 6 wherein said compensation means causes said rapid decrease in the intensity level of said output pulses in response to a predetermined change condition capable of causing user discomfort or possible injury.
8. The device of claim 6 wherein said sample and hold means includes capacitor means for storing a voltage indicative of said sensed change in said predetermined condition being then monitored.
9. The device of claim 6 wherein said compensation means causes said gradual increase in the intensity level of said output pulses over a period of about two seconds.
11. The device of claim 10, wherein said transistor means is an analog control output transistor, and wherein said sample and hold means includes a gate transistor connected between said analog control output transistor and said capacitor means.
13. The pulse width compensation means of claim 12 wherein said electronic means of said pulse width compensation means is a part of a micro-computer controlled by a predetermined algorithm.
14. The pulse width compensation means of claim 13 wherein said electronic device is a TENS-type unit, and wherein said preselected algorithm follows a mathematical formula of I=19.6/(1-e(-0.00305×PW-0.0664)), where I is current and PW is pulse width.
16. The device of claim 15 wherein said device provides output pulses to a plurality of output channels, and wherein said pulse compensation is provided for each of said output channels.
17. The device of claim 16 wherein said device includes a separate amplitude intensity percentage control means for each of said output channels, with each of said amplitude intensity percentage control means providing a separate percent of intensity control for each said channel.
19. The method of claim 18 wherein said method includes allowing the intensity level of said output pulses to be gradually increased over a predetermined period of time toward said prior existing level unless the occurrence of a one of the predetermined condition variation variations capable of causing user discomfort is sensed during said predetermined time period of gradual increases of the intensity level of said output pulses.
21. The method claim 20 wherein said provided pulse compensation causes including to step of causing said corresponding and predetermined change in the range of intensities of said output pulse pulses to be such that the resulting capability to stimulate nerve fiber of the charge delivered per output pulse of said output pulses is maintained substantially constant.
23. The device of claim 22 wherein said method includes causing said rapid decrease in the intensity level of said output pulses in response to a predetermined changed condition capable of causing user discomfort or possible injury.
24. The method of claim 22 wherein said gradual increase in the intensity level of said output pulses occurs over a period of about two seconds.
26. The method of claim 25 wherein said method includes changing the percentage of the amplitude maximum intensity of said delivered pulses independent of any said pulse width change of said delivered pulses.
27. The method of claim 25 wherein said electronic device is a TENS type unit, and wherein said change of said range of intensities follows the mathematical formula of I=19.6/(1-e(-0.00305×PW-0.0664)), where I is current and PW is pulse width.

This invention relates to an electronic device for producing a pulse output signal for therapeutic purposes, and, more particularly, relates to output pulse compensation for such a device.

Electronic devices capable of providing a pulse output signal for therapeutic purposes are now well known, and such devices are known, for example, to include transcutaneous electrical nerve stimulating (TENS) devices and muscle stimulating devices. It is also well known that such devices commonly include externally accessible controls for effecting parameter changes, including changes in pulse width and intensity of the delivered pulses (see, for example, U.S. Pat. No. 4,014,347).

Conventional TENS and muscle stimulator devices commonly use constant current feedback to regulate the charge per pulse. The feedback signal, representing the peak current, is compared with the reference voltage to establish the height of the rectangular pulses, and the reference voltage is usually derived from a variable control device, such as a potentiometer, which serves to control the stimulation intensity. In other words, stimulation amplitude is commonly controlled by varying the peak current of the rectangular current pulses.

It has been found that, at least with respect to TENS devices and muscle stimulator devices, that large pulse widths are useful for short term stimulation since they are more comfortable to the user than narrow pulse width for the stimulation of large muscles. Conversely, narrow pulse widths are more comfortable to the user for stimulating small muscle groups, and narrow pulse widths are particularly well suited for use for long term stimulation which often occurs, for example, in effective stimulation by a TENS unit.

It is usually necessary, or at least desirable, that the pulse width be tuned (i.e., varied) while using the unit. However, since the charge per pulse varies directly with the pulse width, unless the peak current is also adjusted whenever the pulse width is changed, the charge per pulse will also change.

Since stimulation intensities perceived by a user are approximately proportional to the delivered charge per pulse, a wide pulse will acquire a large amount of charge when the intensity control is moved only slightly in the intensity increase direction. Conversely, when the pulse width is narrow, changing the peak current a small amount, by moving the intensity control in the intensity increase direction, will produce a small amount of increase in the charge per pulse. Since pulse width affects the sensitivity of the intensity control where both are utilized in a device, using a pulse width, for example, of greater than about 200 microseconds, causes conventional amplitude controls to become overly sensitive. As a result, pulse widths greater than about 200 microseconds are difficult to control with an ordinary potentiometer-type amplitude, or intensity, control.

In addition, the pulse width of the pulses being delivered sometimes causes confusion with respect to the amount of charge being delivered, or at least perceived to be delivered. For example, if the pulse is 100 ma peak and 200 microseconds wide, the pulse contains 20 microcoulombs charge. While such a charge would normally be too strong to be tolerated with small electrodes such as are commonly used with TENS units, for example, such a charge could easily and safely be tolerated with comfort if sufficiently large electrodes are utilized (i.e., the area of application is made sufficiently greater).

It was therefore found that if the intensity was increased as the pulse width was decreased, and if the intensity was decreased as the pulse width was increased, the charge delivered by the pulses can be controlled to produce a more constant level of stimulation. A strength-duration curve to effect this end was suggested in connection with a diagnostic apparatus (see, U.S. Pat. No. 2,808,826), and has also been suggested for use in connection with TENS units (see U.S. Pat. Nos. 4,431,002 and 4,453,548). In addition, such a curve has been suggested for use in connection with mechanical coupling of pulse width and amplitude controls in a stimulator (see U.S. Pat. No. 4,340,063), such a curve has been suggested for use in connection with scanning output parameters through predetermined ranges to periodically achieve optimum stimulating currents (see U.S. Pat. No. 4,210,151), and such a curve has also been suggested for use in conjunction with strength-duration-rate modulation in a TENS device (see U.S. Pat. No. 4,759,368).

It has also been heretofore suggested that the intensity of the delivered output pulses can be controlled, and gradual increase in such intensity is utilized, for example, in the NuWave® TENS unit now being sold by the assignee of this invention.

Thus, while pulse compensation has heretofore been suggested in connection with therapeutic-type devices, improvements and/or additions to such devices could further improve such devices.

This invention provides improved output pulse compensation for therapeutic-type electronic devices. Output pulse compensation is automatically provided upon sensing of predetermined changed conditions being monitored, and such compensation is preferably accomplished using a micro-computer in devices constructed according to this invention.

When such a changed condition is sensed that is capable of causing user discomfort, or possible injury, the intensity of the pulses then being delivered is quickly reduced and then gradually increased to the full then requested intensity (unless intensity reduction is again effected due to sensing of a condition being monitored) to thus provide a soft-start.

Upon sensing a change in pulse width initiated by a change of the pulse width control, a predetermined corresponding change in the range of intensities of the pulses then delivered is also effected, based upon the nerve fiber strength-duration curve of the pulses, to thereby maintain the charge delivered per pulse substantially constant, with the percentage of intensity of each pulse being also maintained substantially constant unless a change in percentage is initiated by an intensity control that operates independently of the pulse width control.

It is therefore an object of this invention to provide improved output pulse compensation for a therapeutic-type electronic device.

It is another object of this invention to provide improved proved output pulse compensation that is automatically provided upon sensing of a predetermined changed condition being monitored.

It is still another object of this invention to provide improved output pulse compensation by quickly reducing the intensity of pulses then being delivered upon sensing of a monitored condition capable of causing discomfort or injury, and then gradually increasing the intensity to the requested intensity unless again caused to be reduced due to sensing of a monitored condition.

It is another object of this invention to provide improved output pulse compensation for a therapeutic-type electronic device utilizing a change in the range of intensities corresponding in a predetermined manner to a change in pulse width.

It is another object of this invention to provide improved pulse compensation for therapeutic-type electronic device wherein a change in the range of intensities, corresponding in a predetermined manner to a change in pulse width, is based upon a nerve fiber strength-duration curve.

It is still another object of this invention to provide improved pulse compensation for a therapeutic-type electronic device utilizing a change in the range of intensities, corresponding in a predetermined manner to a change in pulse width, to thereby maintain the charge delivered per pulse substantially constant.

It is yet another object of this invention to provide improved compensation for a therapeutic-type electronic device utilizing a micro-computer to sense monitored conditions and cause output pulse intensity changes in response thereto.

With these and other objects in view, which will become apparent to one skilled in the art as the description proceeds, this invention resides in the novel construction, combination, arrangement of parts and method substantially as hereinafter described, and more particularly defined by the appended claims, it being understood that changes in the precise embodiment of the herein disclosed invention are meant to be included as come within the scope of the claims.

The accompanying drawings illustrate a complete embodiment of the invention according to the best mode so far devised for the practical application of the principles thereof, and in which:

FIG. 1 is a block diagram of a TENS unit having output pulse compensation according to this invention supplied by a micro-computer included as a part of the TENS unit;

FIG. 2 is a schematic diagram illustrating an output stage as shown in FIG. 1;

FIGS. 3 through 5 are flow charts illustrating operation of the micro-computer shown in FIG. 1 to control the intensity of the output pubes in response to monitored conditions:

FIG. 6 is a graph of a typical nerve fiber strength-duration curve;

FIG. 7 is a plot of a strength-duration look-up table based upon the strength-duration curve of FIG. 6; and

FIGS. 8A and 8B show a flow chart illustrating operation of the micro-computer shown in FIG. 1 to effect output pulse compensation by varying the range of intensities of the output pulses due to pulse width adjustment.

In this invention, output pulse compensation is automatically provided for a therapeutic-type electronic device when a predetermined change is sensed to occur in a condition being monitored. This includes, for example, monitoring of conditions to prevent user discomfort, or possible injury, due to delivery of output pulses at undesirably high intensity levels, as well as monitoring variations imposed by the user, as, for example, varying the requested pulse width of the pulses to be delivered.

Users have been found to be occasionally startled or even shocked by improper use of nerve stimulators or by defective stimulation units. These incidents are normally characterized by a sudden, perceived increase in the stimulation intensity that surprises the user, and can happen in a number of different ways, including, for example, an abrupt increase in the intensity caused by a requested increase by the intensity control or by a sudden increase in intensity occasioned by battery replacement, loose or intermittent electrode leads, rapid switching between modes, and/or defects causing the device to be reset accidently.

In this invention, monitored conditions are sensed, or detected, preferably using a micro-computer having appropriate algorithms. The algorithms eliminate surprise, and prevent discomfort or possible injury, by resetting the stimulation intensity of the output pulses being then delivered to a low (or zero) level, and then gradually increasing the stimulation intensity up to the level requested by the setting of the intensity control.

Output pulse compensation, according to this invention, is illustrated in FIG. 1 in connection with a TENS device. It is meant to be appreciated, however, that such compensation can be effected with other therapeutic-type devices in the same manner. The TENS device illustrated in FIG. 1 is a plural channel device, but it is meant to be realized that a single channel device could also be utilized.

Referring now to FIG. 1, TENS device 7 includes micro-computer, or controller, 9 that receives an input indicative of intensity, or amplitude, from amplitude control potentiometers 11 and 13 (if plural channels are utilized) and an input indicative of pulse width from pulse width control potentiometer 15. In addition, TENS device 7 can also receive an input indicative of pulse rate from pulse rate control potentiometer 17, as is conventional.

As indicated in FIG. 1, the control inputs (from potentiometers 11, 13, 15 and 17) are coupled to microcomputer 9 (which preferably includes analog-to-digital (A/D) converter 19). Micro-computer 9 is connected with power supply 21 (5 volts), and power supply 21 is connected to battery 23 (9 volts) through on-off switch 25. Battery 23 also provides power to high voltage power inverter 27, which inverter supplies high voltage to the output stages 29 and 31 (if plural channels are utilized), as is conventional for TENS units. The output stage, or stages, are preferably conventional asymmetric biphasic, but can also be symmetrical biphasic.

As also indicated in FIG. 1, a multi-mode operation can be established for the device using latch 33 (a 4 bit latch), to hold the then selected mode, and mode switch 35.

As is conventional, micro-computer 9 generates pulses for each channel utilized (using appropriate algorithms in connection with timer 37, which timer is preferably a part of the micro-computer), and these pulses are coupled to the output stage, or stages, to enable the pulse output signals to be conventionally provided by the device.

As also shown in FIG. 1 micro-computer 9 has also included therein output pulse compensation algorithms and a look-up table with the output being coupled through digital-to-analog (D/A) converter 39 (also preferably a part of micro-computer 9 as shown in FIG. 1). Converter 39 supplies a reference voltage to one input of operational amplifier 41. The other input of operational amplifier 41 is connected with current sense resistor 43, and the output of operational amplifier 41 is coupled to the output stage, or stages. 29 and 31.

Output stages 29 and 31 may be identical and output stage 29 is shown in detail in FIG. 2. As shown, the high voltage is coupled to high voltage gate transistor 47 of output stage 29, and transistor 47 also receives the pulse logic input from micro-computer 9. The output pulses are delivered to a user through lead 49, with the return path from the user being through lead 51, capacitor 53, and diode 55 (with lead 49 being connected to the junction of capacitor 53 and diode 55 through bleed resistor 57).

As also shown in FIG. 2, analog control transistor 59 is connected with the output of operational amplifier 61. Amplifier 61 has one input connected to receive a reference voltage and the other input connected with transistor 59 and is connected with ground through sense resistor 63.

As also shown, a +5 volt power supply is connected to one side of resistor 65. The other side of resistor 65 is connected to one side of diode 67, with the other side of diode 67 being connected to the junction of diode 55 and transistor 59. Gate transistor 69 of sample and hold circuit 71 is connected with the junction of resistor 65 and diode 67 through parallel-connected capacitor 73 and resistor 75 (having resistor 77 to ground connected therewith). The pulse logic from microcomputer 9 is also coupled to transistor 69, and the output from transistor 69 is stored in capacitor 79, which capacitor is connected with A/D convertor 19 of micro-computer 9.

The implementation of the algorithms used in microcomputer 9 (as illustrated in FIGS. 3 through 5) requires the use of the sample-and-hold circuit to measure the output transistor saturation during pulses for each channel (the circuit is necessary only where the pulse rate of the TENS unit is variable since, if the rate is fixed, a simple R-C averaging circuit attached to the analog control transistor drain could produce an appropriate voltage value proportional to the drain voltage during the pulses).

The flow chart, as shown in FIG. 3, provides a test for output errors, the flow chart, as shown in FIG. 4, provides for control of the intensity of the delivered output pulses (preferably every ten milliseconds), and the flow chart, as shown in FIG. 5, provides for mode selection (an intermittent lead routine may also be utilized and differs from the reset routine illustrated in that the intensity is reset to zero and ramp-up requires 2.55 seconds, which is 255 steps of 1/100 second).

The algorithm is initiated by unit reset, change of operating mode, or intermittent lead detection.

When the unit is reset, the initialization of the processor (i.e., the micro-computer) includes slow "ramping" of the intensity setting up to the intensity set by the externally accessible intensity control over a period of 2 seconds. The actual intensity is reset to a binary multiplier factor of "55", which is about 20% of full scale. Then the intensity is ramped up to "255", which is equivalent to a multiplier of 100% of full scale. So whenever the processor resets, the intensity control (or controls if dual channels are being utilized) is checked, and if it is found that the setting of the control, or controls, is at a significant level, then the intensity is ramped slowly up to that level.

Similarly, whenever a change in the mode status is detected, the same two second algorithm is implemented.

Intermittent leads require the most complicated detection algorithm. The algorithm looks for the combination of hard saturation of the output transistors plus greater than 95% of the maximum output voltage from the high voltage inverter power supply (where used in a unit having power conservation that requires monitoring of the saturation of the output transistors, saturation alone would not be a sufficient definition for open electrode leads). An open lead pair means that the supply voltage is at maximum and the output transistor is fully saturated.

To measure the drain voltage of the output transistor, the output stage analog control transistor drain is monitored by sample-and-hold circuit 71, as shown in FIG. 2. Transistor 69 is gated on by the micro-computer during pulses to sample the drain voltage, and this voltage is stored in capacitor 79 until read by A/D converter 19. The drain voltage is converted into binary values from 0 to 255.

Sample and hold circuit 71 measures the drain voltages only in the vicinity of saturation. Drain voltages above about 5 volts are defined as not saturated and produce a maximum A/D output of 255 binary. As can be appreciated from the circuit diagram of FIG. 2, the connection to sample and hold circuit 71 becomes operative only when the drain voltage falls below 5 volts and diode 67 is forward biased.

Micro-computer 9 sees a range of saturation voltages from 0 to 255 binary. A voltage of less than "32" is defined as "hard saturation" while a value of less than "128" is defined as a high impedance electrode circuit. If the value is less than "32", the soft start reset and ramp sequence is started. However, if the value is just less than "128", then an electrode alert light (if utilized) is energized and the reset/ramp sequence is not started. An alert light indication indicates that leads and/or electrodes have too high an impedance and that the user should recheck the electrode system for such things as continuity and moist skin contact.

Output pulse compensation is also automatically provided to maintain the charge delivered per pulse substantially constant when a change occurs in the pulse width of the output pulses then being provided by the device.

To accomplish such compensation the range of the amplitude, or intensity, of the delivered output pulses is adjusted based upon a nerve fiber strength-duration curve, such as illustrated in FIG. 6.

The curve shown in FIG. 6 illustrates the relationship between the amplitude and the width and the resulting capability to stimulate the nerve fiber. From this curve, it can be seen that if the pulses have too low an amplitude (i.e., less than the "rheobase"), the nerve will never be stimulated, even if the pulse width lasts to infinity.

Pulse width compensation includes, basically, using an applicable strength-duration curve to vary the range of the peak current delivered as pulses from the device. In other words, the pulse width, as then set, determines the peak current range of the intensity control. For every pulse width, there is a corresponding current range for the intensity control.

The strength-duration curve shown in FIG. 6 is preferably implemented with a look-up table that can be read by micro-computer 9 and an illustration of such a table, based upon the curve shown in FIG. 6, is set forth in FIG. 7. As illustrated in FIG. 7, at a 50 microsecond pulse width, the intensity is automatically assigned a range of 0 to 100 milliamperes peak, while at 400 microseconds width, the assigned range is 0 to 27 milliamperes peak.

The table, as shown in FIG. 7, was determined imperically and has the following mathematical formula:

I=19.6/(1-e(-0.00305×PW-0.0664)),

where I is current and PW is pulse width.

Whenever a new pulse width is selected by the pulse width control the micro-computer, following the thus established algorithm, determines the appropriate range of current (within which range the intensity varying, or controlling, unit (such as a potentiometer) can operate), and then generates the proper reference voltage within that current range for that pulse width. A flow chart illustrating operation of the micro-computer to effect pulse width compensation is set forth in FIG. 8.

After the determination is made at micro-computer 9, the binary number produced is coupled through D/A converter 39 to generate a reference voltage to be coupled to operational amplifier 41.

Thus, the reference voltage equals the setting percentage (of the intensity control potentiometer) x maximum peak current x K, where K is a scale factor that converts the value to the correct binary number and subsequent voltage for the particular device design.

Because the look-up table establishes a range of the intensities, there is, of course, a family of numerous strength curves one for each possible intensity percentage setting. This enables smooth control and is normally no more distinguishable to a user than is generating the reference voltage directly using a simple potentiometer.

The look-up table, as shown in FIG. 7, is not suitable for all pulse shapes since this table was derived for use with an asymmetrical biphasic pulse generated by a capacitive output stage which has an active charge bleeder circuit, such as is commonly found in TENS-type units. In such a unit, the active bleeder circuit discharges the charge stored in the output capacitors and tissues during the brief rectangular pulses. When the pulse width is narrow and pulse rate is low, the charge can be dissipated with a simple resistor. However, when wide pulses and high pulse rates are used, the bleeder must actively discharge the capacitance by turning on a bleeder transistor between pulses. The time constant and response characteristics of the bleeder circuit partly determine the exact shape of the look-up table curve.

As an example of how the look-up table might need to be changed, when a bleeder circuit is used that discharges the capacitance more slowly, the curve that produces equal sensation is different and has the following mathematical formula:

I=28.125/(1-e(-0.0046389×PW-1)).

The equation has the same form as before, but the rheobase has been shifted to account for the different pulse shape.

For other embodiments of the invention, it would be possible to perform the calculation using the exponential formula every time the pulse width changes. In practice, however, this method appears to be slow, due to the complicated operation, and difficult to implement, at least using an 8 bit micro-controller. It would also be possible to build a compensation control system using analog curve fitting techniques, but this method would appear to require tuning with multiple trim pots and therefore be far more costly.

In practice, a device with output pulse compensation, such as illustrated in FIG. 1, operates in the same manner as does a conventional TENS device, except that compensation is automatically provided by the microcomputer each time the pulse width is changed.

The use of such pulse width compensation will not normally be noticed by a user, particularly since the user is automatically protected, including protection against shock which could otherwise occur, for example, when a large pulse width is selected.

Using pulse width compensation, it is possible to adjust pulse widths while the device is in use and directly compare different pulse widths independent of the intensity (since the percentage of intensity is maintained constant unless the intensity control is also adjusted). Also, the ability to finely control intensity when utilizing wide pulse widths makes exceptionally wide pulse widths practical for use in a general purpose TENS unit or a muscle stimulator unit.

Automatic compensation of the pulse intensity range of the delivered output pulses is achieved as the pulse width is varied. Thus, the pulse height is automatically varied whenever the pulse width is changed to hold the amplitude of sensation constant.

Without an arrangement to automatically vary the intensity control potentiometer (which normally has an externally visible indicator associated therewith), the actual intensity being delivered cannot be correctly portrayed at the intensity control indicator for each of a plurality of pulse widths. The range of intensities is thus changed as the pulse width is changed. The intensity control potentiometer indicator therefore acts as a percentage indicator that consistently indicates whatever percent of the intensity range is then selected by the intensity control potentiometer. Thus, amplitude is defined as a family of strength-duration curves, with each curve representing a separate setting of the intensity control.

As can be appreciated from the foregoing, this invention provides improved output pulse compensation for an electronic device providing a pulse output for therapeutic purposes.

Harris, Frank W., Owens, Alan R.

Patent Priority Assignee Title
10034708, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for thermally-induced renal neuromodulation
10039596, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Apparatus for renal neuromodulation via an intra-to-extravascular approach
10080864, Oct 19 2012 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Packaging for catheter treatment devices and associated devices, systems, and methods
10105180, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for intravascularly-induced neuromodulation
10111707, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Renal neuromodulation for treatment of human patients
10124195, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for thermally-induced renal neuromodulation
10130792, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for therapeutic renal neuromodulation using neuromodulatory agents or drugs
10179020, Oct 25 2010 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Devices, systems and methods for evaluation and feedback of neuromodulation treatment
10179027, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Catheter apparatuses having expandable baskets for renal neuromodulation and associated systems and methods
10179028, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for treating patients via renal neuromodulation
10179235, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for bilateral renal neuromodulation
10194979, Mar 28 2014 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods for catheter-based renal neuromodulation
10194980, Mar 28 2014 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods for catheter-based renal neuromodulation
10245429, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for renal neuromodulation
10272246, Apr 08 2002 Medtronic Adrian Luxembourg S.a.r.l Methods for extravascular renal neuromodulation
10293190, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Thermally-induced renal neuromodulation and associated systems and methods
10328260, Apr 19 2005 DJO, LLC Electrical stimulation device and method for therapeutic treatment and pain management
10376311, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for intravascularly-induced neuromodulation
10376312, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for monopolar renal neuromodulation
10376516, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and devices for renal nerve blocking
10420606, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
10441356, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for renal neuromodulation via neuromodulatory agents
10537385, Dec 31 2008 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Intravascular, thermally-induced renal neuromodulation for treatment of polycystic ovary syndrome or infertility
10537734, Oct 05 2004 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for multi-vessel renal neuromodulation
10561460, Dec 31 2008 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Neuromodulation systems and methods for treatment of sexual dysfunction
10850091, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for bilateral renal neuromodulation
10874455, Mar 08 2012 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Ovarian neuromodulation and associated systems and methods
11033328, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for renal neuromodulation
11338140, Mar 08 2012 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Monitoring of neuromodulation using biomarkers
7158834, Jun 13 2002 ATLANTIC MEDICAL, INC Method and apparatus for performing microcurrent stimulation (MSC) therapy
7162303, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Renal nerve stimulation method and apparatus for treatment of patients
7187977, Jun 13 2002 ATLANTIC MEDICAL, INC Transcutaneous electrical nerve stimulation device and method using microcurrent
7228179, Jul 26 2002 ADVANCED NEUROMODULATION SYSTEMS, INC Method and apparatus for providing complex tissue stimulation patterns
7254444, Oct 17 2001 DJO, LLC Electrical nerve stimulation device
7493159, Jun 19 2000 Medtronic, Inc Trial neuro stimulator with lead diagnostics
7526341, Mar 15 2002 Medtronic, Inc. Amplitude ramping of waveforms generated by an implantable medical device
7617005, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and apparatus for thermally-induced renal neuromodulation
7620451, Dec 29 2005 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
7647115, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Renal nerve stimulation method and apparatus for treatment of patients
7653438, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and apparatus for renal neuromodulation
7717948, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and apparatus for thermally-induced renal neuromodulation
7853333, Oct 05 2004 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and apparatus for multi-vessel renal neuromodulation
7937143, Nov 02 2004 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and apparatus for inducing controlled renal neuromodulation
8019426, Oct 17 2001 DJO, LLC Electrical nerve stimulation device
8131371, Apr 08 2002 MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY Methods and apparatus for monopolar renal neuromodulation
8131372, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Renal nerve stimulation method for treatment of patients
8131374, Oct 17 2001 DJO, LLC Electrical nerve stimulation device
8140165, Jan 28 2005 Encore Medical Asset Corporation Independent protection system for an electrical muscle stimulation apparatus and method of using same
8145316, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and apparatus for renal neuromodulation
8145317, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods for renal neuromodulation
8150518, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Renal nerve stimulation method and apparatus for treatment of patients
8150519, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and apparatus for bilateral renal neuromodulation
8150520, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods for catheter-based renal denervation
8175711, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods for treating a condition or disease associated with cardio-renal function
8347891, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
8398630, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
8428204, Aug 20 2010 Raytheon Company Recovering distorted digital data
8433423, Oct 05 2004 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods for multi-vessel renal neuromodulation
8444640, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
8454594, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Apparatus for performing a non-continuous circumferential treatment of a body lumen
8548600, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Apparatuses for renal neuromodulation and associated systems and methods
8551069, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and apparatus for treating contrast nephropathy
8620423, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods for thermal modulation of nerves contributing to renal function
8620438, Feb 13 2007 DJO, LLC Method and apparatus for applying neuromuscular electrical stimulation
8626300, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and apparatus for thermally-induced renal neuromodulation
8652133, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for performing renal neuromodulation via catheter apparatuses having inflatable balloons
8684998, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for inhibiting renal nerve activity
8721637, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for performing renal neuromodulation via catheter apparatuses having inflatable balloons
8728137, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for thermally-induced renal neuromodulation
8728138, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for thermally-induced renal neuromodulation
8740896, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and apparatus for performing renal neuromodulation via catheter apparatuses having inflatable balloons
8768470, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods for monitoring renal neuromodulation
8771252, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and devices for renal nerve blocking
8774913, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and apparatus for intravasculary-induced neuromodulation
8774922, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods
8784463, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for thermally-induced renal neuromodulation
8805545, Oct 05 2004 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for multi-vessel renal neuromodulation
8818514, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for intravascularly-induced neuromodulation
8845629, Apr 08 2002 MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY Ultrasound apparatuses for thermally-induced renal neuromodulation
8852163, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Renal neuromodulation via drugs and neuromodulatory agents and associated systems and methods
8880186, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Renal neuromodulation for treatment of patients with chronic heart failure
8934978, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for renal neuromodulation
8948865, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for treating heart arrhythmia
8958871, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
8958883, Apr 19 2005 DJO, LLC Electrical stimulation device and method for therapeutic treatment and pain management
8983595, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Renal neuromodulation for treatment of patients with chronic heart failure
8986294, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S A R L Apparatuses for thermally-induced renal neuromodulation
9023037, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Balloon catheter apparatus for renal neuromodulation
9072527, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Apparatuses and methods for renal neuromodulation
9108040, Oct 05 2004 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for multi-vessel renal neuromodulation
9125661, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for renal neuromodulation
9131978, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for bilateral renal neuromodulation
9138281, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for bilateral renal neuromodulation via catheter apparatuses having expandable baskets
9186198, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Ultrasound apparatuses for thermally-induced renal neuromodulation and associated systems and methods
9186213, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for renal neuromodulation
9192715, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for renal nerve blocking
9265558, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for bilateral renal neuromodulation
9289255, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for renal neuromodulation
9308043, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for monopolar renal neuromodulation
9308044, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for therapeutic renal neuromodulation
9314630, Apr 08 2002 MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY Renal neuromodulation for treatment of patients
9320561, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for bilateral renal neuromodulation
9326817, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for treating heart arrhythmia
9327122, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for catheter-based renal neuromodulation
9352151, Feb 13 2007 DJO, LLC Method and apparatus for applying neuromuscular electrical stimulation
9364280, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
9402992, Oct 05 2004 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for multi-vessel renal neuromodulation
9439726, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for therapeutic renal neuromodulation
9445867, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for renal neuromodulation via catheters having expandable treatment members
9456869, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for bilateral renal neuromodulation
9463066, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for renal neuromodulation
9468497, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for monopolar renal neuromodulation
9474563, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for renal neuromodulation
9486270, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for bilateral renal neuromodulation
9636174, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for therapeutic renal neuromodulation
9669211, Feb 13 2007 DJO, LLC Method and apparatus for applying neuromuscular electrical stimulation
9669212, Apr 19 2005 DJO, LLC Electrical stimulation device and method for therapeutic treatment and pain management
9675413, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for renal neuromodulation
9707035, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for catheter-based renal neuromodulation
9731132, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for renal neuromodulation
9743983, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Renal neuromodulation for treatment of patients
9757192, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Renal neuromodulation for treatment of patients
9757193, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Balloon catheter apparatus for renal neuromodulation
9808619, Jan 28 2005 DJO, LLC Independent protection system for an electrical muscle stimulation apparatus and method of using same
9814873, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for bilateral renal neuromodulation
9827040, Apr 08 2002 Medtronic Adrian Luxembourg S.a.r.l. Methods and apparatus for intravascularly-induced neuromodulation
9827041, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Balloon catheter apparatuses for renal denervation
9895195, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods for therapeutic renal neuromodulation
9907611, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Renal neuromodulation for treatment of patients
9950161, Oct 05 2004 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for multi-vessel renal neuromodulation
9956410, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and apparatus for renal neuromodulation
9968611, Apr 08 2002 MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L. Methods and devices for renal nerve blocking
9980766, Mar 28 2014 MEDTRONIC ARDIAN LUXEMBOURG S A R L Methods and systems for renal neuromodulation
RE40279, Jun 26 1997 Covidien AG; TYCO HEALTHCARE GROUP AG Method and system for neural tissue modification
RE41045, Jun 27 1996 Covidien AG Method and apparatus for altering neural tissue function
Patent Priority Assignee Title
2263205,
2808826,
3241557,
3645267,
3842844,
3901247,
3908669,
4014347, May 27 1975 REHABILLICARE, INC Transcutaneous nerve stimulator device and method
4088141, Apr 27 1976 STIMTECH PRODUCTS, A GENERAL PARTNERSHIP OF MA Fault circuit for stimulator
4141359, Aug 16 1976 UNIVERSITY OF UTAH RESEARCH FOUNDATION THE Epidermal iontophoresis device
4177819, Mar 30 1978 PROMATEK INDUSTRIES LTD Muscle stimulating apparatus
4210151, Sep 26 1978 STIMTECH PRODUCTS, INC Electronic pain control with scanned output parameters
4340063, Jan 02 1980 Empi, Inc. Stimulation device
4372319, Jun 15 1979 Matsushita Electric Works, Ltd. Low frequency therapeutic instrument
4431002, Jun 08 1981 EMPI Inc. Modulated deep afferent stimulator
4453548, Jun 08 1981 Empi, Inc. Method of improving sensory tolerance with modulated nerve stimulator
4520825, Apr 30 1982 MEDTRONIC, INC , A CORP OF Digital circuit for control of gradual turn-on of electrical tissue stimulators
4539993, Nov 18 1982 Medtronic, Inc. Fail-safe muscle stimulator device
4759368, Dec 02 1986 SPARTA SURGICAL CORPORATION Transcutaneous nerve stimulator
4926865, Oct 01 1987 Microcomputer-based nerve and muscle stimulator
4979507, May 10 1988 ALT, ECKHARD U , DR Energy saving cardiac pacemaker
EP269844,
EP269848,
EP339313,
FR2336286,
FR2504807,
FR2526180,
FR2528709,
WO8602567,
/////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Feb 08 1995Staodyn, Inc.(assignment on the face of the patent)
Nov 20 2007Encore Medical Asset CorporationCREDIT SUISSE, AS COLLATERAL AGENTSECURITY AGREEMENT0202340433 pdf
May 07 2015CREDIT SUISSE AG, AS COLLATERAL AGENTDJO, LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0357060497 pdf
May 07 2015CREDIT SUISSE AG, AS COLLATERAL AGENTEncore Medical Asset CorporationRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0357060497 pdf
May 07 2015CREDIT SUISSE AG, AS COLLATERAL AGENTRikco International, LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0357060497 pdf
Date Maintenance Fee Events
Jul 31 2000M284: Payment of Maintenance Fee, 8th Yr, Small Entity.
Sep 08 2004M2553: Payment of Maintenance Fee, 12th Yr, Small Entity.
Sep 08 2004M2556: 11.5 yr surcharge- late pmt w/in 6 mo, Small Entity.


Date Maintenance Schedule
Dec 08 20014 years fee payment window open
Jun 08 20026 months grace period start (w surcharge)
Dec 08 2002patent expiry (for year 4)
Dec 08 20042 years to revive unintentionally abandoned end. (for year 4)
Dec 08 20058 years fee payment window open
Jun 08 20066 months grace period start (w surcharge)
Dec 08 2006patent expiry (for year 8)
Dec 08 20082 years to revive unintentionally abandoned end. (for year 8)
Dec 08 200912 years fee payment window open
Jun 08 20106 months grace period start (w surcharge)
Dec 08 2010patent expiry (for year 12)
Dec 08 20122 years to revive unintentionally abandoned end. (for year 12)